ASO Author Reflections: Utilizing National Databases to Identify Areas of Future Focus When Studying Rare Tumors

  title={ASO Author Reflections: Utilizing National Databases to Identify Areas of Future Focus When Studying Rare Tumors},
  author={Samantha M. Ruff and Danielle K. DePeralta},
  journal={Annals of Surgical Oncology},
  pages={8329 - 8329}
Due to the rarity of some tumors, data are limited to small case series of 10–15 patients seen over a severaldecades-long period. As a result, these tumors are often grouped with histologically and/or anatomically similar tumors for staging and prognostic information. One potential solution comes in the form of national databases such as the National Cancer Database (NCDB), which can provide a window into these rare diseases. Our paper used this strength of the NCDB to investigate 872 patients… 



Ampullary Neuroendocrine Tumors: Insight into a Rare Histology

Based on the clinicopathologic and survival data, ampullary NETs have a unique underlying biology compared with duodenal and pancreatic head NETs.

ASO Visual Abstract: Ampullary Neuroendocrine Tumors—Insight into a Rare Histology

This study uses a national database to evaluate clinicopathologic factors and overall survival of this rare tumor and demonstrates that ampullary NETs likely have a different underlying biology than duodenal and pancreatic head NETs.

Duodenal, ampullary, and pancreatic neuroendocrine tumors: Oncologic outcomes are driven by tumor biology and tissue of origin

Duodenal and ampullary NETs are rare and may have distinct biologic behavior from pancreatic NETs (P‐NETs), and the outcomes of these entities are examined.

AJCC Cancer Staging Manual 8th Edition

  • Education
  • 2020
Getting the screenshots prepared is a good approach that might time savings. But having screenshots already prepared in addition to callouts, explanations, and annotations is an excellent approach

insight into a rare histology

  • Ann Surg Oncol. 2021. h ttps:// Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Society of Surgical Oncology 2021 First Received: 2 July 2021 Accepted: 2 July 2021; Published Onl
  • 2021